Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2007; 13(7): 985-992
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.985
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.985
Strategies | Therapeutic effects |
Chemotherapy or radiotherapy | Inducing p53-dependent apoptosis in tumor cells with wt-p53 |
Supplying exogenous wt-p53 by gene delivery | Suppressing growth of both mutant and wild-type p53-containing tumor cells |
Overexpression of ARF | Blocking p53 degradation pathways to induce p53 triggered tumor cell death |
Interruption of MDM2-p53 interaction | Preventing MDM2-mediated p53 ubiquitinationand degradation to restore transactivation |
Molecules stabilizing the active conformation of the protein | Rescuing mt-p53 to restore p53 function |
-
Citation: Guan YS, La Z, Yang L, He Q, Li P. p53 gene in treatment of hepatic carcinoma:
Status quo . World J Gastroenterol 2007; 13(7): 985-992 - URL: https://www.wjgnet.com/1007-9327/full/v13/i7/985.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i7.985